US Stock MarketDetailed Quotes

GNTA Genenta Science

Watchlist
  • 3.400
  • +0.100+3.03%
Close May 28 16:00 ET
61.94MMarket Cap-4892P/E (TTM)

Genenta Science Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-51.05%-11.21M
-6.61%-7.42M
-15.11%-6.96M
-142.74%-6.04M
-2.49M
Net income from continuing operations
-37.36%-11.65M
-53.32%-8.48M
1.12%-5.53M
-21.63%-5.59M
---4.6M
Operating gains losses
-16.23%75.69K
582.90%90.36K
118.48%13.23K
24.43%6.06K
--4.87K
Depreciation and amortization
591.42%42.45K
25.59%6.14K
157.32%4.89K
--1.9K
--0
Change In working capital
-273.78%-417.6K
112.36%240.3K
-111.15%-1.94M
-168.04%-920.72K
--1.35M
-Change in prepaid assets
-35.96%-554.04K
9.46%-407.49K
0.88%-450.09K
-400.54%-454.08K
--151.09K
-Change in payables and accrued expense
-147.58%-405.06K
168.33%851.32K
-358.72%-1.25M
-115.32%-271.59K
--1.77M
-Change in other current assets
239.50%596.94K
-44.76%-427.91K
-47.59%-295.6K
65.98%-200.29K
---588.68K
-Change in other current liabilities
-124.71%-55.44K
372.61%224.37K
805.51%47.48K
-71.25%5.24K
--18.24K
Cash from discontinued investing activities
Operating cash flow
-51.05%-11.21M
-6.61%-7.42M
-15.11%-6.96M
-142.74%-6.04M
---2.49M
Investing cash flow
Cash flow from continuing investing activities
-54,915.39%-14.89M
-200.48%-27.07K
56.83%-9.01K
-20.87K
0
Net PPE purchase and sale
49.05%-13.79K
-200.48%-27.07K
56.83%-9.01K
---20.87K
--0
Net investment purchase and sale
---14.88M
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-54,915.39%-14.89M
-200.48%-27.07K
56.83%-9.01K
---20.87K
--0
Financing cash flow
Cash flow from continuing financing activities
531
0
1,968.80%28.74M
-90.59%1.39M
14.77M
Net common stock issuance
--531
--0
1,815.55%28.74M
-90.05%1.5M
--15.09M
Proceeds from stock option exercised by employees
--0
--0
--543
--0
--0
Net other financing activities
----
----
----
65.11%-111.12K
---318.51K
Cash from discontinued financing activities
Financing cash flow
--531
--0
1,968.80%28.74M
-90.59%1.39M
--14.77M
Net cash flow
Beginning cash position
-19.99%29.79M
140.80%37.24M
-23.22%15.47M
156.14%20.14M
--7.86M
Current changes in cash
-250.52%-26.1M
-134.19%-7.45M
565.66%21.77M
-138.09%-4.68M
--12.28M
Effect of exchange rate changes
---6.28K
--0
--0
----
----
End cash Position
-87.61%3.69M
-19.99%29.79M
140.80%37.24M
-23.22%15.47M
--20.14M
Free cash flow
-50.68%-11.22M
-6.86%-7.45M
-14.87%-6.97M
-143.57%-6.07M
---2.49M
Currency Unit
EUR
EUR
EUR
EUR
EUR
Audit Opinions
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
Unqualified Opinion
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -51.05%-11.21M-6.61%-7.42M-15.11%-6.96M-142.74%-6.04M-2.49M
Net income from continuing operations -37.36%-11.65M-53.32%-8.48M1.12%-5.53M-21.63%-5.59M---4.6M
Operating gains losses -16.23%75.69K582.90%90.36K118.48%13.23K24.43%6.06K--4.87K
Depreciation and amortization 591.42%42.45K25.59%6.14K157.32%4.89K--1.9K--0
Change In working capital -273.78%-417.6K112.36%240.3K-111.15%-1.94M-168.04%-920.72K--1.35M
-Change in prepaid assets -35.96%-554.04K9.46%-407.49K0.88%-450.09K-400.54%-454.08K--151.09K
-Change in payables and accrued expense -147.58%-405.06K168.33%851.32K-358.72%-1.25M-115.32%-271.59K--1.77M
-Change in other current assets 239.50%596.94K-44.76%-427.91K-47.59%-295.6K65.98%-200.29K---588.68K
-Change in other current liabilities -124.71%-55.44K372.61%224.37K805.51%47.48K-71.25%5.24K--18.24K
Cash from discontinued investing activities
Operating cash flow -51.05%-11.21M-6.61%-7.42M-15.11%-6.96M-142.74%-6.04M---2.49M
Investing cash flow
Cash flow from continuing investing activities -54,915.39%-14.89M-200.48%-27.07K56.83%-9.01K-20.87K0
Net PPE purchase and sale 49.05%-13.79K-200.48%-27.07K56.83%-9.01K---20.87K--0
Net investment purchase and sale ---14.88M--0--0--------
Cash from discontinued investing activities
Investing cash flow -54,915.39%-14.89M-200.48%-27.07K56.83%-9.01K---20.87K--0
Financing cash flow
Cash flow from continuing financing activities 53101,968.80%28.74M-90.59%1.39M14.77M
Net common stock issuance --531--01,815.55%28.74M-90.05%1.5M--15.09M
Proceeds from stock option exercised by employees --0--0--543--0--0
Net other financing activities ------------65.11%-111.12K---318.51K
Cash from discontinued financing activities
Financing cash flow --531--01,968.80%28.74M-90.59%1.39M--14.77M
Net cash flow
Beginning cash position -19.99%29.79M140.80%37.24M-23.22%15.47M156.14%20.14M--7.86M
Current changes in cash -250.52%-26.1M-134.19%-7.45M565.66%21.77M-138.09%-4.68M--12.28M
Effect of exchange rate changes ---6.28K--0--0--------
End cash Position -87.61%3.69M-19.99%29.79M140.80%37.24M-23.22%15.47M--20.14M
Free cash flow -50.68%-11.22M-6.86%-7.45M-14.87%-6.97M-143.57%-6.07M---2.49M
Currency Unit EUREUREUREUREUR
Audit Opinions Unqualified OpinionUnqualified Opinion with Explanatory NotesUnqualified OpinionUnqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg